Effect of armodafinil on cognition in patients with HIV/AIDS and fatigue

Journal of Clinical and Experimental Neuropsychology

Volumn 35, Issue 7, 2013, Pages 718-727

  McElhiney, Martin ^a,b   Rabkin, Judith ^a,b   Van Gorp, Wilfred ^a   Rabkin, Richard ^a,b  

^a Columbia University ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Armodafinil; Cognitive impairment; Fatigue; HIV AIDS; Neuropsychological impairment

Indexed keywords

ARMODAFINIL; BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADDICTION; ADULT; AGED; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EMPLOYMENT; FATIGUE; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VERBAL BEHAVIOR; VIRUS LOAD; YOUNG ADULT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; BENZHYDRYL COMPOUNDS; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; COGNITION DISORDERS; DATA INTERPRETATION, STATISTICAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; EMPLOYMENT; FATIGUE; FEMALE; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RNA, VIRAL; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; VERBAL BEHAVIOR; VIRAL LOAD; YOUNG ADULT;

EID: 84884908268     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803395.2013.823910     Document Type: Article

References (44)

1. Abolfazli, R., Hosseini, M., Ghanizadeh, A., Ghaleiha, A., Tabrizi, M., Raznahan, M., . . . Akhondzadeh, S. (2011). Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression. Depression & Anxiety, 28, 297-302.
2. Adler, C. H., Caviness, J. N., Hentz, J. G., Lind, M., & Tiede, J. (2003). Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Movement Disorders, 18, 287-293. (Pubitemid 36410825)
3. Albert, S., & Rabkin, J. (2008). General health status, functioning and disability measures. In A. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (pp. 107-123). Washington, DC: American Psychiatric Publishing.
4. Al-Khindi, T., Zakzanis, K., & van Gorp, W. (2012). Does antiretroviral therapy improve HIV-associated cognitive impairment? Journal of the International Neuropsychological Society, 17, 956-969.
5. Antinori, A., Arendt, G., Becker, J., Brew, B., Byrd, D., Cherner, M., . . . Wojna, V. E. (2007). Updated research criteria for HIV-associated neurocognitive disorders. Neurology, 69, 1789-1799. (Pubitemid 350059308)
6. Ballon, J., & Feifel, D. (2006). A systematic review of modafinil: Potential clinical uses and mechanisms of action. Journal of Clinical Psychiatry, 67, 554-566. (Pubitemid 43764232)
7. Barroso, J., Hammill, B., Leserman, J., Salahuddin, N., Harmon, J., & Pence, B. (2010). Physiological and psychosocial factors that predict HIV related fatigue. AIDS Behavior, 14, 1415-1427.
8. Broadbent, D. E., Cooper, P. F., Fitzgerald, P., & Parkes, K. (1982). The Cognitive Failures Questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology, 21, 1016.
9. Brown, G. R. (1995). The use of methylphenidate for cognitive decline associated with HIV disease: Stimulant use in consultation patients. International Journal of Psychiatry in Medicine, 25, 21-37.
10. Cooper, M., Bird, H., & Steinberg, M. (2009). Efficacy and safety of modafinil in the treatment of cancerrelated fatigue. Annals of Pharmacotherapy, 43, 721-725.
11. Cysique, L. A., Franklin, D., Abramson, I., Ellis, R. J., Letendre, S., Collier, A., . . . Heaton, R. (2011). Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. Journal of Clinical & Experimental Neuropsychology, 33, 505-522.
12. DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, L. R., & Poirer, J. A. (2004). Prospective trial of modafinil as an adjunctive treatment of major depression. Journal of Clinical Psychopharmacology, 24, 87-90. (Pubitemid 38134171)
13. D'Elia, L., Satz, P., Uchiyama, C., & White, T. (1996). Color Trails Test. Odessa, FL: Psychological Assessment Resources.
14. Devlin, K., Gongvatana, A., Clark, U., Chasman, J., Westbrook, M., Tashima, K., . . . Cohen, R. (2012). Neurocognitive effects of HIV, hepatitis C, and substance use history. Journal of the International Neuropsychological Society, 18, 68-78.
15. Dinges, D. F., & Weaver, T. (2003). Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP. Sleep Medicine, 4, 393-402. (Pubitemid 37193022)
16. Durvasula, R., Norman, L., & Malow, R. (2009). Current perspectives on the neuropsychology of HIV. In C. Pope, R. White, & R. Malow (Eds.), HIV/AIDS: Global frontiers in prevention/intervention (pp. 177-190). New York, NY: Routledge.
17. Golden, C. J. (1978). StroopWord and Color Test: A manual for clinical and experimental uses. Chicago, IL: Stoetling.
18. Harsh, J. R., Hayduk, R., Rosenberg, R., Wesnes, K., Walsh, J., Arora, S., . . . Roth, T. (2006). The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Current Medical Research and Opinions, 22, 761-774.
19. Heaton, R. K., Clifford, D. B., Franklin, D., Jr., Woods, S. P., Ake, C., Vaida, F., . . . Grant, I. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: Charter Study. Neurology, 75, 2087-2096.
20. Hinkin, C., Castellon, S., Hardy, D. F., Farinpour, R., Newton, T., & Singer, E. (2001). Methylphenidate improves HIV-associated cognitive slowing. Journal of Neuropsychiatry & Clinical Neuroscience, 13, 248-254. (Pubitemid 32499677)
21. Hirshkowitz, M., Black, J., Wesnes, K., Niebler, G., Arora, S., & Roth, T. (2007). Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respiratory Medicine, 101, 616-627. (Pubitemid 46196315)
22. Jenkin, P., Koch, T., & Kralik, D. (2006). The experience of fatigue for adults living with HIV. Journal of Clinical Nursing, 15, 1123-1131. (Pubitemid 44213899)
23. Jong, E., Oudhoff, L., Epskamp, C., Wagener, M., Van Duijn, M., Fischer, S., & Van Gorp, E. (2010). Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral era. AIDS, 24, 1387-1405.
24. Koback, K., Skodol, A., & Bender, D. (2008). Diagnostic measures for adults. In A. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (pp. 35-60). Washington, DC: American Psychiatric Publishing.
25. Krupp, L., LaRocca, N., Muir-Nash, J., & Steinberg, A. (1989). The Fatigue Severity Scale. Archives of Neurology, 46, 1121-1123.
26. Maj, M., D'Elia, L., Satz, P., Janssen, R., Zaudig, M., & Uchiyama, C. (1993). Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: The WHO Study. Archives of Clinical Neuropsychology, 8, 123-135. (Pubitemid 23079256)
27. Matthews, C., & Klove, H. (1964). Instruction manual for the Adult Neuropsychology Test Battery. Madison, WI: University of Wisconsin Medical School.
28. McElhiney, M., Rabkin, J., van Gorp, W., & Rabkin, R. (2010). Modafinil effects on cognitive function in HIV+ patients treated for fatigue: A placebo controlled study. Journal of Clinical & Experimental Neuropsychology, 32, 474-480.
29. Mitrushina, M. N., Boone, K. B., & D'Elia, L. F. (1999). Handbook of normative data for neuropsychological assessment. New York, NY: Oxford University Press.
30. Rabkin, J., Gordon, P., McElhiney, M., Rabkin, R., Chew, S., & Mitsumoto, H. (2009). Modafinil treatment of fatigue in patients with ALS: A placebo controlled study.Muscle & Nerve, 39, 297-303.
31. Rabkin, J., McElhiney, M., & Rabkin, R. (2011). Treatment of HIV-related fatigue with armodafinil: A placebo controlled randomized trial. Psychosomatics, 52, 328-336.
32. Rammohan, K., Rosenberg, J., Lynn,D., Blumenfeld, A., Pollak, C., & Nagaraja, H. (2002). Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: A two-centre Phase 2 study. Journal of Neurology, Neurosurgery & Psychiatry, 72, 179-183.
33. Randall, D. C., Shneerson, J., Plaha, K., & File, S. (2002). Modafinil affects mood, but not cognitive function, in healthy young volunteers. Human Psychopharmacology, 18, 163-173.
34. Schouten, J., Cinque, P., Gisslen, M., Reiss, P., & Portegies, P. (2011). HIV-1 and cognitive impairment in the cART era: A review. AIDS, 25, 561-575.
35. Spreen, O., & Strauss, E. (1998). A compendium of neuropsychological tests (2nd ed.). New York, NY: Oxford University Press.
36. Urbano, F., Leznik, E., & Llinas, R. (2007). Modafinil enhances thalamocortical activity by increasing neuronal electronic coupling. PNAS, 104, 12554-12559. (Pubitemid 47206176)
37. Valcour, V. (2011). Evaluating cognitive impairment in the clinical setting: Practical screening and assessment tools. Topics in Antiviral Medicine, 19, 175-180.
38. Volkow, N., Fowler, J., Logan, J., Alexoff, D., Zhu, W., Telang, F., . . . Apelskog-Torres, K. (2009). Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications. Journal of the American Medical Association, 301, 1148-1154.
39. Wechsler, D. (1997). Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). San Antonio, TX: The Psychological Corporation.
40. Williams, J. B. W. (2008). Mental health status, functioning and disabilities measures. In A. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (pp. 83-105). Washington, DC: American Psychiatric Publishing.
41. Woods, S. P., Moore, D. J., Weber, E., & Grant, I. (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychological Review, 19, 152-168.
42. Wright, E. (2011). Neurocognitive impairment and neuroCART. Current Opinions in HIV and AIDS, 6, 303-308.
43. Yonkers, K., & Samson, J. (2008). Mood disorders measures. In A. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (pp. 499-528). Washington, DC: American Psychiatric Publishing.
44. Young, J., & Geyer, M. (2010). Action of modafinil- Increased motivation via the dopamine transporter inhibition and D1 receptors? Biological Psychiatry, 67, 784-787.